Search results
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 hours agoSixteen Researchers from Florida Cancer Specialists & Research Institute Share Cancer Care Discoveries at 2024 ASCO® Annual Meeting PR Newswire FORT MYERS ...
Targeting 'monster cancer cells' could reduce recurrence rates after cancer therapy
Medical Xpress· 1 day agoBoth types of therapy put cancer cells under stress, with the goal of causing them to self-destruct. Recently, scientists have begun to look at the role of polyploid giant ...
Communication and Common Goals in Metastatic Breast Cancer
Medscape· 7 days agoHarold J. Burstein, MD, PhD: I'm Dr. Harold Burstein, and this is Care Cues, a conversation about...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 5 days agoFN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention, diagnosis, and ...
Integration of pharmacies with physician practices has little impact on cancer drug expenditures,...
Medical Xpress· 5 days agoIn addition, there were no discernible benefits for patients as measured by out-of-pocket expenditures, medication adherence, and the amount of time before treatment of cancer
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoMenarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer< ...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 6 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Mercy Bioanalytics Pushing Forward with Plans to Market Ovarian Cancer Blood Test
GenomeWeb News· 1 day agoExtracellular vesicle diagnostics firm Mercy Bioanalytics is making progress in its plans to market and eventually garner US Food and Drug Administration approval for a novel ...
Panel recommends blood test to detect colon cancer for FDA approval
UPI· 6 days agoMay 23 (UPI) -- A panel of U.S. Food and Drug Administration advisers on Thursday recommended...
...Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer at the 2024 ASCO Annual...
WJTV Jackson· 6 days agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical Oncology ...